focus -WSS

focus

author：leisure time 2025-09-29 21:26:02 - browse：6

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Latigo launches with $135 million for Vertex

WSS

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Websites selling Wegovy, Zepbound ingredients targeted by FDA

John Green on his newest strategy for fighting tuberculosis

Resistance to opioid

Why scientists need input from humanists on sensitive research

Readout Newsletter: CAR

Wikipedia

focus

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Psychedelics group wrestles with new pharma identity

First U.S. drug developed to treat liver disease MASH is approved

Virginia high school admissions case could be legal follow

Tome Biosciences co

Wildfire smoke exposes gaps in outdoor worker protections

Report cites 'urgent' need to recruit more diverse clinical trial participants

New air purifier tech could be key to improving indoor air quality

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Affirmative action in medical school literally saved lives

ACIP vaccine advisory panel sees its vacancies filled

focus

Why depression after traumatic brain injury is distinct

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Ebola: Gilead Sciences antiviral shows promise as new treatment

Latigo launches with $135 million for Vertex

HHS secretary Becerra pressed on Change HealthCare cyberattack

Change Healthcare outage fallout shows need for new oversight

explore

hotspot

Wikipedia

hotspot